[Indications for the use of granulocyte growth factors].
Elonen
E
E
HYKS:n sisätautien klinikka, Helsinki.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D009503:Neutropenia / Q000139:chemically induced / Q000628:therapy; D016032:Randomized Controlled Trials as Topic
D000970:Antineoplastic Agents; D016179:Granulocyte Colony-Stimulating Factor